Inhalation

INH1023

Issue link: https://www.e-digitaleditions.com/i/1509606

Contents of this Issue

Navigation

Page 27 of 42

26 OctOber 2023 Inhalation Dry powder inhalation capsule portfolio Lonza's Capsugel ® Zephyr™ dry powder inhalation (DPI) capsule portfolio is a comprehensive capsule product offering, featuring customized DPI capsules and dedicated equipment in place for efficient, phase- appropriate capsule filling. e Zephyr DPI portfolio addresses the need for highly customized solutions for pulmonary route delivery methods and is supported by Lonza's inhalation and drug development and par- ticle engineering capabilities. is integrated product and service offering can enable consistent and optimal release performance for inhalation drugs. Lonza Capsules & Health Ingredients US: +1 888 783-6361 www.capsugel.com Inhaled and nasal drug delivery systems RxPack is a global leader in pharmaceutical dispensing solutions and inhaled and nasal drug delivery sys- tems. Specializing in pMDIs, it offers valves suitable for solution and suspension formulations, single- and double-stage filling and combination or single for- mulations. Low moisture ingress and fast filling are among key features. Valves and actuators are avail- able for HFA 134a and green gasses. RxPack can also guide customers from R&D to full-scale manufac- turing. For pMDI filling equipment, RxPack works in partnership with Coster, which manufactures lab- scale machines and high-speed lines. RxPack S.r.l. Italy: +39 0341 18960 info@rxpack.it www.rxpack.eu An advanced aerosol generator PreciseInhale ® is the advanced aerosol generator sometimes known as "e Inhalation Switchboard" because it can consistently generate aerosol from several sources (DPIs, MDIs, nebulizers, dry pow- ders), enabling precision dosing across a wide range of advanced in vitro and in vivo exposure modules, minimizing translational errors and generating com- parative and more predictive data. e extensive range of high-precision exposure modules minimizes errors, reduces risk and accelerates drug development. Inhalation Sciences Sweden: +46 705 625 195 contact@inhalation.se www.inhalation.se

Articles in this issue

Links on this page

view archives of Inhalation - INH1023